Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

Stanley Cohen, Eric Hurd, John Cush, Michael Schiff, Michael E. Weinblatt, Larry W. Moreland, Joel Kremer, Moraye B. Bear, William J. Rich, Dorothy McCabe

Research output: Contribution to journal › Article › peer-review